Scribd Logo
Upload

Welcome to Scribd!

  • 45 views

    Moneycontrol P&L

    Uploaded by

    veda sai kiranmayee rasagna somaraju AP22322130023
    Ajanta Pharma reported its standalone profit and loss figures for the past 5 fiscal years. For fiscal year 2022, Ajanta Pharma reported total revenue of Rs. 3,280.37 crores, profit before tax of Rs. 900.54 crores, and profit after tax of Rs. 719.86 crores. Earnings per share for the year was Rs. 83.28. Dividend per share declared for fiscal 2022 was Rs. 82.21.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Moneycontrol P&L

    Uploaded by

    veda sai kiranmayee rasagna somaraju AP22322130023
    45 views2 pages
    Ajanta Pharma reported its standalone profit and loss figures for the past 5 fiscal years. For fiscal year 2022, Ajanta Pharma reported total revenue of Rs. 3,280.37 crores, profit before tax of Rs. 900.54 crores, and profit after tax of Rs. 719.86 crores. Earnings per share for the year was Rs. 83.28. Dividend per share declared for fiscal 2022 was Rs. 82.21.

    Original Title

    Moneycontrol.P&L

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Ajanta Pharma reported its standalone profit and loss figures for the past 5 fiscal years. For fiscal year 2022, Ajanta Pharma reported total revenue of Rs. 3,280.37 crores, profit before tax of Rs. 900.54 crores, and profit after tax of Rs. 719.86 crores. Earnings per share for the year was Rs. 83.28. Dividend per share declared for fiscal 2022 was Rs. 82.21.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    45 views2 pages

    Moneycontrol P&L

    Uploaded by

    veda sai kiranmayee rasagna somaraju AP22322130023
    Ajanta Pharma reported its standalone profit and loss figures for the past 5 fiscal years. For fiscal year 2022, Ajanta Pharma reported total revenue of Rs. 3,280.37 crores, profit before tax of Rs. 900.54 crores, and profit after tax of Rs. 719.86 crores. Earnings per share for the year was Rs. 83.28. Dividend per share declared for fiscal 2022 was Rs. 82.21.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 2

    1/31/23, 9:43 AM Ajanta Pharma | Standalone Profit & Loss account > Pharmaceuticals > Standalone Profit &

    it & Loss account of Ajanta Pharma -…

    This data can be easily copy pasted into a Microsoft Excel sheet PRINT
    Ajanta Pharma Previous Years »
    Standalone Profit & Loss account ------------------- in Rs. Cr. -------------------
      Mar 22 Mar 21 Mar 20 Mar 19 Mar 18

      12 mths 12 mths 12 mths 12 mths 12 mths

    INCOME
    Revenue From Operations [Gross] 3,083.78 2,674.10 2,167.07 1,731.36 1,762.69
    Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 5.10
    Revenue From Operations [Net] 3,083.78 2,674.10 2,167.07 1,731.36 1,757.59
    Other Operating Revenues 56.86 44.49 29.35 41.26 67.76
    Total Operating Revenues 3,140.64 2,718.59 2,196.42 1,772.62 1,825.35
    Other Income 139.73 103.57 184.20 102.15 73.01
    Total Revenue 3,280.37 2,822.16 2,380.62 1,874.77 1,898.36
    EXPENSES
    Cost Of Materials Consumed 773.04 704.09 556.22 388.71 375.43
    Purchase Of Stock-In Trade 116.12 100.59 98.73 70.79 73.01
    Changes In Inventories Of FG,WIP And
    -56.60 -74.60 9.02 -67.39 -49.15
    Stock-In Trade
    Employee Benefit Expenses 585.87 498.11 437.82 389.37 342.89
    Finance Costs 9.12 6.90 9.10 0.41 0.24
    Depreciation And Amortisation Expenses 120.96 111.49 91.29 69.90 57.14
    Other Expenses 831.32 573.49 561.85 509.93 536.36
    Total Expenses 2,379.83 1,920.07 1,764.03 1,361.72 1,335.92
      Mar 22 Mar 21 Mar 20 Mar 19 Mar 18

      12 mths 12 mths 12 mths 12 mths 12 mths

    Profit/Loss Before Exceptional,


    900.54 902.09 616.59 513.05 562.44
    ExtraOrdinary Items And Tax
    Exceptional Items 0.00 0.00 -3.92 0.00 0.00
    Profit/Loss Before Tax 900.54 902.09 612.67 513.05 562.44
    Tax Expenses-Continued Operations
    Current Tax 196.72 225.06 168.09 108.66 114.60
    Deferred Tax 9.51 9.77 3.45 12.63 20.32
    Tax For Earlier Years -25.55 -8.38 0.00 0.00 0.00
    Total Tax Expenses 180.68 226.45 171.54 121.29 134.92
    Profit/Loss After Tax And Before
    719.86 675.64 441.13 391.76 427.52
    ExtraOrdinary Items
    Profit/Loss From Continuing
    719.86 675.64 441.13 391.76 427.52
    Operations
    Profit/Loss For The Period 719.86 675.64 441.13 391.76 427.52
      Mar 22 Mar 21 Mar 20 Mar 19 Mar 18

      12 mths 12 mths 12 mths 12 mths 12 mths

    OTHER ADDITIONAL INFORMATION


    EARNINGS PER SHARE
    Basic EPS (Rs.) 83.28 77.59 50.55 44.51 48.59
    Diluted EPS (Rs.) 83.28 77.59 50.55 44.51 48.58
    VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS
    STORES, SPARES AND LOOSE TOOLS

    https://www.moneycontrol.com/stocks/company_info/print_main.php 1/2
    1/31/23, 9:43 AM Ajanta Pharma | Standalone Profit & Loss account > Pharmaceuticals > Standalone Profit & Loss account of Ajanta Pharma -…

    DIVIDEND AND DIVIDEND PERCENTAGE


    Equity Share Dividend 82.21 82.90 113.44 79.22 0.00
    Tax On Dividend 0.00 31.64 2.48 0.37 0.00
    Equity Dividend Rate (%) 475.00 475.00 650.00 450.00 0.00

    Source : Dion Global Solutions Limited

    https://www.moneycontrol.com/stocks/company_info/print_main.php 2/2

    You might also like